GET THE APP

A Comparative Study of Marketing Conditions and Labelling Requirements for Homeopathic Drug in US, Europe and India | Abstract

Asian Journal of Pharmaceutical Technology and Innovation (ajpti)

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

A Comparative Study of Marketing Conditions and Labelling Requirements for Homeopathic Drug in US, Europe and India

Abstract

Pathan Asmatbanu Mehmood Khan1, Dilip G. Maheshwari2*

India is the country which exporting the homeopathic drug product to the foreign countries like USA, Germany and United Kingdom. 90-95% of homeopathic products are exported to Germany from India. Since 1992-93, Indian Homeopathic product is increasing for USA. India also exports to the developing countries like Russia Ukraine and Sri lanka. For Sri lanka export is increasing since 1992-93. The OTC homeopathic drug products in US the established annual sales are around $ 75 million and exploring up to 15-20% annually. The Federal, Food, Drug and Cosmetic Act standardize as official drugs and its standard in Homeopathic Pharmacopoeia of United State (HPUS) and its supplements. According to article 1of Directive 92/73/EC of homeopathic medicinal product means any medicinal product formulated products or substances or composition known as homeopathic stocks according to homeopathic manufacturing process stated in European pharmacopoeia or in absence pharmacopoeia available and currently used in official member states. Central Council for Research in Homeopathy (CCRH) was built up as an independent association in 1978, under the Dept. of AYUSH, Ministry of Health and Family Welfare, and Govt. of India. The National Institute of Homeopathy (NIH) in Kolkata as a self-governing association under the Ministry of Health and Family Welfare, Government of India.

Share this article